ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000876.1|Nikkomycin_1 # 72 # 2105 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.732	BGC0000876.1|Nikkomycin_1 	72	2105	+	Loose	1000	164.466	almE	26.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGTCAACCCGATTCATGACGACAACGGTGCCTGCCTGGTCCTGGTGAACAGCGAGAACCGGCACGCTCTGTGGGCCGACGGCCCCGACGTACCACCGGGCTGGCGCGTCGCGCACCGGGCGGCCGGCCGCCGGGAGTGCCTGGAGTACATCGGCGCCCACTGGCCGGACATCCGGCCCGCCAGACTCCCGGACACCGGGAAGGACGCGGGCGCCTGCCTGCACGACCTGTTCGCCGCCCAGGTCGCGCGCACCCCCGGGGCGCCGGCCCTGATCTGGCGGGACCATGAGATCTCGTACCGTCAACTCGACGACGACTCCAGCAAGTTGGCCGCATACCTGCGGCTGCGCGGCGTGGGGCCCGGCGCGTTCGTGGGCCTGTGCGTCGAGCGGTCGCCGCAGATGATCACGGCCCTGCTCGGCGTCCTGAAGACCGGCGCCGCCTACGTGCCCCTCGACCCCGAGTACCCGGTCGAGCGGCTGCGGTACGTCCTGTCCGACACGGGAGCACGCCTGCTCCTGACCCAGGAGCCGCTGAGGCCGCTCTTCCCCGACCACGACGGCGAGATCCTCTGCCTCGACCAGCACCGGCAGGACATCGACGCGCTGGCCGCCGCGCCCGCACCGGACAGCCCCGTCCCGCTGCCGTCGGACACCGCCTACGTCATCCACACCTCCGGCTCCACGGGCCGCCCCAAGGGCGTCCTGGTGACGCACCGCTCCCTGGCGAACCACAGCTCTGCCGTGAACCGGTACTTCGCCTTCGCCCCCGGCGACCGCGTCCTGCAGTGCAGGCCGCTGAGCTTCGACGCCGCTGCCGAGGAGATCTTCCCGCCGCTCCTGCACGGCGCGGCCCTCGTCCTCGGCAGCGACCCCCTGCGCCAGACGTTCCGGGCCCTGACCCAGCAGGTCATCGACACCGGCACGACCTTCCTGAGCGTGCCCACGGCCTTCTGGCACAGCTGGGTCGCGGAGGAGGACTGCCTGCTGCGGCTGGCCACGGAGTCCGCGCTGCGCACGATGATCGTGGCCGGTGAGAAGGCGGCCCGTCAGGCCCTGCTGACCTGGAAGAAACGGGTCGGCGAGGACATCCGCTGGTTCAACGTCTACGGCCCCACCGAGGGCACCATCACCACGACGGTCCACGAGCCGGGCGCCGACTGGGAGACCGGCGAGTACGGCTCCGTCCCGATCGGCCGCCCCATCGACAACGTCCGCACGTACGTCCTCGACGACGCCCTGCGGCCGGTCCCGGCGGGAGAGCCGGGCGAGCTGTTCATCGGCGGGGCGGGCGTGGCCGTCGGCTACCTGAACGCGCCGCAGACCACCGCCGAGCGGTTCCTGCCCGACCCCTTCTCCGGCGTGCCCGGCAGCCGGCTCTACCGCACCGGGGACCTGGTGCGCGCGGACGCCGACGGCTGCCTGGAGTTCCTCGGCCGCCGGGACCACCAGGTGAAACTGCGCGGTTACCGCATCGAGCCCGGCGAGATCGAGGCCGTGCTCACCGAGCACGAGGACGTCCGGGCGTGCGTCGCCCTGGTGACCGACGACGGCCCCGACAGTGCCCTCGTGTGCTTCGTGACCGCGGGTGGGCGGGCCGCGCCGCCGGCCGCCGAACTGATCGCCCACCTGCGCGGCCGGCTGCCCTGGTACATGATCCCGACGGCCGTCCACGTCCTGGACGCCTTCCCCCTGACCCCCAACGGGAAGATCGACCGGGCCGCCCTGCTCGCCCTCGAACCCGACGACGACGGCGAAGCCGTCCACATCGCGCCGCGCACCCCCGAGGAAGCGGTCCTGGCCGACATCTGGGAGGACATCCTCGGCCGCCGCGGCATCAGCGTCGACGCCGACTTCTTCCAGGTGGGCGGCCACTCCCTGCTCGCCGCGAGCCTCATCGCCCGCATCCGCGCCCGGTTCGACGTCGCCATGACGGCCCGCGTGCTGTTCGAGTCCCCGACCATCGCCGGGCTCGCCGAAGCCGTCACCCGGGCGACCGGCGACGGCGCGGCGGCCCGCGCCGGACGGAGCTGA	MVNPIHDDNGACLVLVNSENRHALWADGPDVPPGWRVAHRAAGRRECLEYIGAHWPDIRPARLPDTGKDAGACLHDLFAAQVARTPGAPALIWRDHEISYRQLDDDSSKLAAYLRLRGVGPGAFVGLCVERSPQMITALLGVLKTGAAYVPLDPEYPVERLRYVLSDTGARLLLTQEPLRPLFPDHDGEILCLDQHRQDIDALAAAPAPDSPVPLPSDTAYVIHTSGSTGRPKGVLVTHRSLANHSSAVNRYFAFAPGDRVLQCRPLSFDAAAEEIFPPLLHGAALVLGSDPLRQTFRALTQQVIDTGTTFLSVPTAFWHSWVAEEDCLLRLATESALRTMIVAGEKAARQALLTWKKRVGEDIRWFNVYGPTEGTITTTVHEPGADWETGEYGSVPIGRPIDNVRTYVLDDALRPVPAGEPGELFIGGAGVAVGYLNAPQTTAERFLPDPFSGVPGSRLYRTGDLVRADADGCLEFLGRRDHQVKLRGYRIEPGEIEAVLTEHEDVRACVALVTDDGPDSALVCFVTAGGRAAPPAAELIAHLRGRLPWYMIPTAVHVLDAFPLTPNGKIDRAALLALEPDDDGEAVHIAPRTPEEAVLADIWEDILGRRGISVDADFFQVGGHSLLAASLIARIRARFDVAMTARVLFESPTIAGLAEAVTRATGDGAAARAGRS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	121.76	gnl|BL_ORD_ID|4935|hsp_num:0	5928			69	1668	colistin A; colistin B
BGC0000876.1|Nikkomycin_2 # 2112 # 2933 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.755	BGC0000876.1|Nikkomycin_2 	2112	2933	+	Loose	500	26.1794	CTX-M-151	31.11	3002008	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGGCACCGCGACAGGCCGCCGCCACGCGCCCGGACAGCCCCTGGCTGCGCACCTTCGGCCCGCCGAGGCCTGCGGCCCCGGCCCGGCTCGTGTGCTTCCCGCACGCCGGGGGCGCGGCCAGCTACTTCCGGGACTGGGGCGGCCGTGACCTCGCCGGGGCCGAGGTGTGGGCCGTCCAGTACCCGGGCCGCGAGAACCGGATCCGGGAGGGGTTCCCGCCCGACCTGCACACCCTCGCCGACCAGGTCACCGGGGAGCTGCGCGGACTCCTCGACCGGCCCGCCGTCTTCTTCGGGCACAGCATGGGCGCCGTCGTCGGCTACGAGGTCCTGCGCCGCCTCACGGCCGACGGCCGGGGCGGCGCCGTACTCCACCTCGTGGTCTCGGGGTGCGGCGCCCCCCAGCGGGTGCGCCCCTTCGCCGGACAGGAAGGTGCCCACCTCCTGGACGACGACCGGCTCGTGGCGCTCCTCAAGGAGCTGGGCTCGGGCAACGCCGGCCTGCTCGACGACCCGGACATGCGCTCGGTCTTCCTGCCGGCGGTCCGCGACGACTACCGCATCGTCCAGTCCTACGTCCCGCGCGCCGGCGGCCCGCTCCTGCGGACCGACGTCACCGCGTTCGTGGGCCGCCAGGACGAGGCGGTCGGCGTCGGCGACGCGGGCGCCTGGGCCGGCGCGACCCTGGGCCGCTTCACGCTCCGCACCTTCCCCGGCGGCCACTTCTACCTGGGAGAACACCCGGACCACGTCCTGCACGCCCTGCGCGAGGTCCTCCTTTCCGCCACCACGATCGACACCGGGAGAGCCGATGAGAGTTGA	MAPRQAAATRPDSPWLRTFGPPRPAAPARLVCFPHAGGAASYFRDWGGRDLAGAEVWAVQYPGRENRIREGFPPDLHTLADQVTGELRGLLDRPAVFFGHSMGAVVGYEVLRRLTADGRGGAVLHLVVSGCGAPQRVRPFAGQEGAHLLDDDRLVALLKELGSGNAGLLDDPDMRSVFLPAVRDDYRIVQSYVPRAGGPLLRTDVTAFVGRQDEAVGVGDAGAWAGATLGRFTLRTFPGGHFYLGEHPDHVLHALREVLLSATTIDTGRADES	MINKRLSIALALAAMIGTPVAMALESQKPGSDSANHIQHQMVQQLSALEKSANGRLGVAVIDTGSGAIAGWRMDEPFPMCSTSKVMAVAALLKQSEQTPELMSQPQPVASGDLVNYNPITERFVGKSMTFDELSAATLQYSDNAAMNLILAKLGGPQKVTAFARSIGDDKFRLDRNEPSLNTAIPGDLRDTSTPRAMALSLQKLALGDALGQVQREKLSHWLRGNTTGAASIRAGLPSGWSVGDKTGSGDYGTTNDIAVVWPTGRPPLVIVTYFTQPQQQAESQRPVLAKAAAIVASHYVLPKG	89.80	gnl|BL_ORD_ID|331|hsp_num:0	362			366	489	
BGC0000876.1|Nikkomycin_3 # 2923 # 4113 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.694	BGC0000876.1|Nikkomycin_3 	2923	4113	+	Loose	680	25.7942	LpeA	29.23	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGAGTTGACCTGTCCGACCCGCTCTTGTACCGGGACTCCGACCCCGAACCGGTCTGGTCGCGGCTGCGCGCCGAACACCCCGTCTACCGCAACGAGCGGGCCAACGGGGAGCACTTCTGGGCGGTGATGACCCACGGCCTGTGCACCGACATGCTGACCGACCCCCGCGTGTTCAGCTCCCAGAACGGGATGCGCCTCGACTCCGACCCGCAGGTCCTCGCCGCCGCGGCCGGCAAGATGCTCAACATCACCGACCCGCCCCGGCACGACAAGATCCGCAAGGTCGTCAGCTCGGCGTTCACCCCGCGCATGGTGAGCCGGCTGGAGGCCACCATGCGCGAGACGGCCGCCAAAGCCATCGACGAGGCGCTGGCCGCGGGGGAGTGCGAGTTCACGCGCGTCGCCCAGAAACTGCCGGTCTCGGTCATCTGCGACATGCTCGGCGTCGCACCCGCCGACTGGGACTTCATGGTCGAGCGCACCCGCTTCGCCTGGAGCTCCACCGCCCTCGACGAGGCGGAGGAGGCGCGCAAGGTCCGGGCCCACACCGAGATCCTGCTCCACTTCCAGGACCTCGCCGCGGAGCGCAGGCGGGAGCCGAAGGACGACCTCATGAGCGCCCTGGTGTGCGGCGAGATCGACGGCGCCCCGCTGACCGACCAGGAGATCCTCTACAACTGCGACGCCCTGGTCTCCGGCGGCAACGAGACGACCCGGCACGCCACCGTCGGCGGGCTGCTCGCCCTCATCGACAACCCGGATCAGTGGCACCGGCTGCGCGACGAGCCCGCCCTCATGCCCTCGGCGATCCAGGAGATCGTGCGCTACACCTCGCCTGTCATGCACGCGCTGCGCACCGCGACCGAGGACGTCGAGTTCGGCGGGGAGCGGATCAGCGCCGGGGACCACGTCGTCGCCTGGCTGCCCTCGGCCAACCGCGACGAGAAGGTCTTCGACGACCCCGACCGCTTCGACATCGAGCGCGAACCCAACCGCCACCTGGGCTTCATCCAGGGCAACCACTACTGCATCGGCTCCTCGCTCGCCAAGCTCGAACTCACGGTGATGTTCGAGGAACTCCTGGCGCGGGTCGAGGTCGCCGAACTCGCCGGCCAGGTCCGCCGCCTGCGCTCGAACCTGCTGTGGGGGTTCGACTCGCTTCCCGTGAAATTCGTCCCGAGGGCCTGA	MRVDLSDPLLYRDSDPEPVWSRLRAEHPVYRNERANGEHFWAVMTHGLCTDMLTDPRVFSSQNGMRLDSDPQVLAAAAGKMLNITDPPRHDKIRKVVSSAFTPRMVSRLEATMRETAAKAIDEALAAGECEFTRVAQKLPVSVICDMLGVAPADWDFMVERTRFAWSSTALDEAEEARKVRAHTEILLHFQDLAAERRREPKDDLMSALVCGEIDGAPLTDQEILYNCDALVSGGNETTRHATVGGLLALIDNPDQWHRLRDEPALMPSAIQEIVRYTSPVMHALRTATEDVEFGGERISAGDHVVAWLPSANRDEKVFDDPDRFDIEREPNRHLGFIQGNHYCIGSSLAKLELTVMFEELLARVEVAELAGQVRRLRSNLLWGFDSLPVKFVPRA	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	111.55	gnl|BL_ORD_ID|2386|hsp_num:0	2758			264	444	erythromycin; spiramycin; azithromycin
BGC0000876.1|Nikkomycin_4 # 4127 # 4807 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000876.1|Nikkomycin_4 	4127	4807	+	Loose	550	26.9498	IMI-13	42.86	3006177	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGACCGCGCCCACCGCCCCCTCGACCGACACATACCTCGGCACCAATGTCCGTCTGCTGCCCCAGACCGACCAGCTGCGCGCCCTGCACACCGCGATCCGCGACCGGGACGCCAGCCACGAGGACTTCGTCCGCTACTCGCGCCGGATCATCCGCCTGCTGATCGAGGCGGGCATGGACCTGCTGCCCTTCGAGCCGCACGAGGTCCGCACCCCGACCGGCGCCGCCTACCAGGGGCTGCGCTTCGCCTCCGGGCTGTGCGGGGTCACCGTGGTGCGCGCCGGGGAGAGCATGGAGGGCGAACTGCGGGACGTCTGCCCGGGGATCAGGATCGGGAAGATCCTCATCCAGCGGGACGAGACGACCAAAGAGGCCCGCCTCTACTACACCTCCCTGCCCGCCGACATCGCCCGGCGGCACGTGCTGCTCCTCGACCCGGTCATGGCGACCGGCGGGACCGCGCTGGCGGCGCTGCGCGTGCTGACAGACCTCGGCGTGCCCGAGGAGAACATCGTCTTCGTCAACTTCATCACCGTCCCCGAGGGCATCACCGCCTTCTGCGGGCAGTACCCGCGGGTGCGGATCGTGACCTCCGCCATCGAGGAGCGGCTGACCGAGGACGCGTGGATGCTGCCCGGCATCGGGGACTTCGGGGACCGCTACTTCGGCACGGACGACTGA	MTAPTAPSTDTYLGTNVRLLPQTDQLRALHTAIRDRDASHEDFVRYSRRIIRLLIEAGMDLLPFEPHEVRTPTGAAYQGLRFASGLCGVTVVRAGESMEGELRDVCPGIRIGKILIQRDETTKEARLYYTSLPADIARRHVLLLDPVMATGGTALAALRVLTDLGVPEENIVFVNFITVPEGITAFCGQYPRVRIVTSAIEERLTEDAWMLPGIGDFGDRYFGTDD	MSLNAKPSRIGILFSSCLVLISFFSQANTKGIDEIKSLETDFNGRIGVYALDTGSGKSFSYRANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYSTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERFIGGPEGMTKFMRSIGDEVFRLDRWELDLNTAIPGDERDTSTPAAIGKSLENLALGNILSEREKETYQTWLKGNTTGATRIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKNQKEAKHDDKVIAEASRIAIDNLK	77.40	gnl|BL_ORD_ID|3598|hsp_num:0	4667			342	459	
BGC0000876.1|Nikkomycin_5 # 4876 # 6150 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.708	BGC0000876.1|Nikkomycin_5 	4876	6150	+	Loose	350	34.2686	vanD	23.65	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAAGGCCGAACAGGGGCCGTTTCTGCTGCTGAACACCAAGAAGATCGTCTCGCGCCTGCACGAGTGGTTCCCCGACGCGGCGCGGGAGCTGGTCGTGGTGACCACGAAAGCGGACATCCCCTCCGCCGACATCTCCGCGTACGCACGACGCTTCCTCCACCTGGAGGTGGTGCCCAACCTCTGGGAGCTGTCGGACGACGAACTCCTGGCCCTCGCCCGGCGGTTCGGCGTACGCCGGATCCTGTCGCTCGGCGAGCGCGAGGTGCTGCGCGCGGCACGCATACGGGCCGAACTCGGCCTGCCCGGCCAGAGCCTCGCCTCGGCCACGGCGTACCGGGACAAGCACGTCATGAAGTCGACCCTGGCGGCGGCGGGCATCGACGTCGCCCCCATGCGCAAGTTCCGGACCAACGACGACCTCGCCGAGTTCGCGTGGAAGGTCGGCTTCCCGGTCGTCGTCAAGGAACTCGACTCCGGCGCGTCGAACGGCACGGTGGTCCTGATGGACGAGGAGGACCTGCGCGCCCTCCCGGAGCGTGCCACCGCGGCGCCCCGGCTGGCCGAAGCCTGGGTCGAGGGCGACTTCTACCACGTCAACGGCCTCATGAAGGACGGCGAGGTGGTGCTCGCGGTGCCCTCCCGCAACCTGTACTCCGACTGGTTCTCGGTCGCCTACGACGCCCCGACCATGACGGGGATGATGCCCGACGACCACCCCCTGTCCGAGCGGCTGCGCAGTACCGCGCGGCAGGTCGTGGCCGCGCTTCCCGCCGTACCCGACCTGTGCGCCTTCCACCTCGAACTGTTCCACACCGCCGACGACCGCGTGGTCGTCTGCGAGATCGCCTGCCGTGCGGGCGCGGCCCTCGTCAGCGACGTCCACGAAGCGGTGCTGGGCGTGAACTTCCACGGCGCGAGCCTGCTCGGCCAGGCCGGACGCGGTGACCAGGTCGAGATCCGGCCGACCGGCGAACGGCTCGGCTTCGTCTGGTTCCCGCCGGCCAAGGGAGTGCTGCGCGCGCTGCCCGACACGTGCCCGCTGCCGGGGACGGTGAGCTACCGGCCCTGCGGCGACATCGGACGCCGCTACGGCAGTTCCTCCGGACTCGGCCGGCCCATCGCCGAGATGGTCTTCCGGCTCACCGAGCCGGACACCGGGGCGGAGCTGCGGCGGATCGAGGAGTGGTGGGACGACAACGTCGTCTGGGAGCACCGGACCAACGCGGTGCCCGACCGCTGGAAGACGCCCCGAAGGAAGCCGGCCGACGCGTAG	MKAEQGPFLLLNTKKIVSRLHEWFPDAARELVVVTTKADIPSADISAYARRFLHLEVVPNLWELSDDELLALARRFGVRRILSLGEREVLRAARIRAELGLPGQSLASATAYRDKHVMKSTLAAAGIDVAPMRKFRTNDDLAEFAWKVGFPVVVKELDSGASNGTVVLMDEEDLRALPERATAAPRLAEAWVEGDFYHVNGLMKDGEVVLAVPSRNLYSDWFSVAYDAPTMTGMMPDDHPLSERLRSTARQVVAALPAVPDLCAFHLELFHTADDRVVVCEIACRAGAALVSDVHEAVLGVNFHGASLLGQAGRGDQVEIRPTGERLGFVWFPPAKGVLRALPDTCPLPGTVSYRPCGDIGRRYGSSSGLGRPIAEMVFRLTEPDTGAELRRIEEWWDDNVVWEHRTNAVPDRWKTPRRKPADA	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	123.62	gnl|BL_ORD_ID|759|hsp_num:0	824			345	933	vancomycin; teicoplanin
BGC0000876.1|Nikkomycin_6 # 6178 # 7500 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.736	BGC0000876.1|Nikkomycin_6 	6178	7500	+	Loose	500	28.1054	APH(3')-Va	30.0	3002649	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGTACGAACTGCTGAAGACGATCATGATCGAGGAGCTGGAGGTGGAGGCCGGCCAGGTGTCCCCGGACGCGAGCCGCGAGGACGCCGGCCTGGACTCCCTCGCCACCTTCGAACTCTCCCTGGCGCTCAGCCAGCGCCTCGGCGTCACCATCGCCGACGAGGACCTGTTCGGACTCAGGACGCTGGCGGACATCGCCGAGTTCCTGGAGAAGCGCACCGCCGGCCTGCCGGGCTCCCCGGGAACATCCGGATCTCCGGCGGCGGACCAGGCCGAGGGCCGCGAGCACGCCGGGCTCACCCGGCTGCTCGGCACCGGGGACGGCGTCCACCCCGGCGGGCCCGCCCCCGCCCACCAACTCGCCCGCAACGAAAACCCGTTCCAGCCCCCAGCGTCCGTGCTGGACGCGATCACCCGCGCCGCCGCCGAGGCCAACCGGTACCCGGACCCGGCCTGCGAAGCGCTGCGCGCCGCGCTCGCCCGGCACTACGGCCTCTTCCCGGACCGCGTCGCGGTGGGCGCCGGATCGATCACGCTCCTCCAGGCACTGCTCACGGTGACCGCCGGACCGGGAGCAGCCGTCGCCTACTCGTGGCCGTCCTTCGACGGCTACGAGGTGCTCGCGGACCTCGCCGGATTCCGCACGGTACGGGTCCCGCTGGCCGAGGACGGGCACGACCTCGACGCCCTGGCCGCGGCGGTCGACGAGCACACCCGCCTGGTGCTGCTCTGCAACCCCAACAACCCCACCGGCACCGCGTCGGGCGAGGCCGACCTCCTGCGGTTCCTCGACGCCGTGCCGCGCACGTGCCTGGTCGTGCTCGACGAGGCGTACTGCGAATACGCGCGCGACCCCGGCCTCGGCGCCCGCCTCCTCACCTCGTGGCCGAACCTGATCGTCGCCCGCACCTTCTCCAAGGCGTACGGCCTCGCCGGCATGCGCGTCGGCTATCTGCTCGCGGAACCCGGCCTGATCTCCCGCGTCCACCGCATGGTCATGCCGTTGAGCGTCAGTGACGTCGCCCAGGCCGCCGCCGTCGCGTCGCTGGCGGCGGAGAAGGAGCTCCTCGGCCGCGTCCGGGAAACGGCCGCCGAACGGGACCGCGTCCGCGCCGCGCTGCTCGCCCTGGGATTCGACGTGCCGCCCTCGGAGGCGAACTTCCTCTGGCTCCCGCTCGGCGCCCGCGCCGAGGAGTTCGCCGCCGCGTGCGCGTCGGCCGGAGTCGCCGTACGGCCCTACCCGGGTGACGGCGTGCGCGTGACGACAGGAACCGCGGAGGACAACGACGCGTTCCTGGCAGCGGCCGAGATGAACCGCCCGTGA	MYELLKTIMIEELEVEAGQVSPDASREDAGLDSLATFELSLALSQRLGVTIADEDLFGLRTLADIAEFLEKRTAGLPGSPGTSGSPAADQAEGREHAGLTRLLGTGDGVHPGGPAPAHQLARNENPFQPPASVLDAITRAAAEANRYPDPACEALRAALARHYGLFPDRVAVGAGSITLLQALLTVTAGPGAAVAYSWPSFDGYEVLADLAGFRTVRVPLAEDGHDLDALAAAVDEHTRLVLLCNPNNPTGTASGEADLLRFLDAVPRTCLVVLDEAYCEYARDPGLGARLLTSWPNLIVARTFSKAYGLAGMRVGYLLAEPGLISRVHRMVMPLSVSDVAQAAAVASLAAEKELLGRVRETAAERDRVRAALLALGFDVPPSEANFLWLPLGARAEEFAAACASAGVAVRPYPGDGVRVTTGTAEDNDAFLAAAEMNRP	MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEADRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARALHELPVEDCPSDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAYAERFLERYGAHRVDKEKLAFYQLLDEFF	164.18	gnl|BL_ORD_ID|30|hsp_num:0	38			93	345	neomycin; ribostamycin; paromomycin
BGC0000876.1|Nikkomycin_7 # 7536 # 7964 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.646	BGC0000876.1|Nikkomycin_7 	7536	7964	+	Loose	700	29.6462	oleD	30.0	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGACCAGCGTGTCGTCGGATTCCCACATGTGGAACCTCGTTTTCCTCCAGTTGCTGCTCGAGGAGAACGGCGGGAAGGTGATCAACCTCGGCGCGTGCACTCCGGACGAACTGGTCATGTCCGAATGCCTCAGAATCCGGCCGGACGCCTTGGTCATCAGCACGGTCAACGGACACGGCCACATCGACGGCCTACGGCTGATCAGAAAGATTCGCGGGCATGCGGTGCTCGCTTCCATGAAAGTCGTCATCGGCGGGAAGCTCGGCGTCCACGGTTCCCGGCAGGCGGGATCCCGGGCGGAACTGGTGGCGAACGGCTTCGACGCGGTGTTCGAGGCGGACGCCGATCTCGACCGGTTCCTCGACTGCCTCAGCCTGGGCACGCCCGCGCCGCAACGCGTCGCCTCCACGGAAATCTGGAGCACCTGA	MTSVSSDSHMWNLVFLQLLLEENGGKVINLGACTPDELVMSECLRIRPDALVISTVNGHGHIDGLRLIRKIRGHAVLASMKVVIGGKLGVHGSRQAGSRAELVANGFDAVFEADADLDRFLDCLSLGTPAPQRVASTEIWST	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	34.22	gnl|BL_ORD_ID|1253|hsp_num:0	1367			18	168	erythromycin; tylosin
BGC0000876.1|Nikkomycin_8 # 7964 # 9235 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.692	BGC0000876.1|Nikkomycin_8 	7964	9235	+	Loose	600	25.7942	APH(9)-Ib	33.71	3002663	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGGCACCTCCCACCGGCCCCGGACGCTTCACCCGGTTCGTCCGGCGGGCGTCGAGCGAAGGGAAACTGGTCGTCCAGCCGCGCATGGGGTTCGGCACGGTCGAGCAGATGCGCGCGGGACTCGACGCGGTCAGGATCGTCGACGCGGCCACGGTGGGCACCATCACCGTCGACAGCTACACGCGGGTGAACGATCACGCCTCGGCCCTTCTCGCTCTGGAGAAGGGCGCGGACCTCAACGGGTTCCCGCTGGTGGCCCACGGCGCGGCGGCCACCCGCGAGCTGCTCGCCGGAATCGCGGGCGACGACTTCCCGGTGCAGGTGAGGCACGGCTCGGCGTTGCCCGGCGCATTGTTCGAGGGACTGGTGGCGGCCGGCATCGACGCCACCGAAGGCGGCCCTGTCTCCTACTGCCTGCCGTATAGCCGCGTCCCTCTGGCGCAAGCCGTCGACGCCTGGGCGGAATGCTGCGAGATGCTCGCGGGAACCAGCGAACCGGTGCATCTGGAGAGTTTCGGCGGCTGTATGCTGGGACAGTTGTGCCCGCCGAGCCTGTTGATCTCCCTGAGCATTCTGGAAGGCTTGTTCTTCCGCGAACACGGACTGCGGGACATTTCCGTCAGCTACGCCCAGCAGACGAATCAGCAACAGGACCTCGAGGCGATCCACGCCCTGCGCGCCCTGGCGAAGGAATGGCTCGGAGACACCGACTGGCACGCCGTCCTGTACACCTACATGGGCGTTTATCCCCGCACCCGGCAGGGGGCGTACAGGCTCCTCGAGGAGAGTGCGAGGCTCGCCGCCAGATCCGGGACCGAGCGGTTGATCGTCAAGACCGCGGTGGAGGCCAGCAGAATCCCGTCGATCACGGAGAACGTCGACGCCCTGGAACGCGCCGCGAGGGCGGCCGAGCGGGAGGCGGTGGCCGAACCGGCCGGAATCCCGGACTCCGGGATCTACGAGGAGGCCCAGGCGATCATCACGCACACGCTGACCCTCGGCAGTGATGTCGGAAAGGCGCTCGTCCGCGCGTTCGCCCTCGGACACCTCGACATCCCGTTCTGCCTGCACCAGGACAACGCGAACCGCTGCCGGGCCCGGCATCGACGACCGTGGCCGGCTCACCTGGGCCGACCCCGCAGGTGGCCGATTCCCCGGGCGCGCGCTCTGCCCGGGAACCGGCAGCGGCTCACCGCCCGGGGCCTCCTCGAGATGCTCAGTTACAACGAACGGCGCTACGACCACCCGCCCCGGACCAGCCACCCTCGTTGA	MAPPTGPGRFTRFVRRASSEGKLVVQPRMGFGTVEQMRAGLDAVRIVDAATVGTITVDSYTRVNDHASALLALEKGADLNGFPLVAHGAAATRELLAGIAGDDFPVQVRHGSALPGALFEGLVAAGIDATEGGPVSYCLPYSRVPLAQAVDAWAECCEMLAGTSEPVHLESFGGCMLGQLCPPSLLISLSILEGLFFREHGLRDISVSYAQQTNQQQDLEAIHALRALAKEWLGDTDWHAVLYTYMGVYPRTRQGAYRLLEESARLAARSGTERLIVKTAVEASRIPSITENVDALERAARAAEREAVAEPAGIPDSGIYEEAQAIITHTLTLGSDVGKALVRAFALGHLDIPFCLHQDNANRCRARHRRPWPAHLGRPRRWPIPRARALPGNRQRLTARGLLEMLSYNERRYDHPPRTSHPR	MEDLPENLDQESLFQGLREFGISTTSASYAPLGFGDYHWHITGDDGQRWFATVSDLEHKEHCGHGAPAALRGLRRAMDTAVHLREQGGLPFVVAPRTTSDGASLVPLDSRYALTVFPHVSARPGEFGQKLTERERDQVLVLLAELHGQAPPKCTPTTDMVPTGLDGVHTALAEPSGTWTGGPFSEPARELLAEHEATLRGRMAEFGELVARVRGRGAPLVVTHGEPHPGNLILGEDGYVLVDWDTVGLAIPERDLSLISDDPAALARYTELTGHTPDPAALALYRLRWSLLDVAEFVEWFRGEHQRTSDTEAAWQSFAETLDHLNSEVPS	128.18	gnl|BL_ORD_ID|969|hsp_num:0	1059			465	702	spectinomycin
